These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 142459)
21. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Hyman BT; West HL; Rebeck GW; Lai F; Mann DM Arch Neurol; 1995 Apr; 52(4):373-8. PubMed ID: 7710373 [TBL] [Abstract][Full Text] [Related]
22. Cytogenetic findings in leukemic cells of 56 patients with constitutional chromosome abnormalities. A cooperative study. Groupe Français de Cytogénétique Hématologique. Cancer Genet Cytogenet; 1988 Oct; 35(2):243-52. PubMed ID: 2972356 [TBL] [Abstract][Full Text] [Related]
23. APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome. Deb S; Braganza J; Norton N; Williams H; Kehoe PG; Williams J; Owen MJ Br J Psychiatry; 2000 May; 176():468-72. PubMed ID: 10912224 [TBL] [Abstract][Full Text] [Related]
24. The link between Down's syndrome and Alzheimer's disease: 1. Soliman A; Hawkins D Br J Nurs; 1998 Jul 9-22; 7(13):779-84. PubMed ID: 9732570 [TBL] [Abstract][Full Text] [Related]
25. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Fong CT; Brodeur GM Cancer Genet Cytogenet; 1987 Sep; 28(1):55-76. PubMed ID: 2955886 [TBL] [Abstract][Full Text] [Related]
26. Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome. Hunter MP; Nelson M; Kurzer M; Wang X; Kryscio RJ; Head E; Pinna G; O'Bryan JP Neuroreport; 2011 Oct; 22(15):767-72. PubMed ID: 21876463 [TBL] [Abstract][Full Text] [Related]
27. Chromosome 21, Down's syndrome and Alzheimer's disease. St Clair D J Ment Defic Res; 1987 Jun; 31 ( Pt 2)():213-4. PubMed ID: 2957506 [No Abstract] [Full Text] [Related]
28. Familial Down's syndrome. A cytogenetical and genealogical study of twenty-two families. Mikkelsen M Ann Hum Genet; 1966 Nov; 30(2):125-46. PubMed ID: 4226277 [No Abstract] [Full Text] [Related]
29. Nonrandom chromosomal aberrations and clonal chromosomal evolution in acute leukemia associated with Down's syndrome. Wang N; Leung J; Warrier RP; Schorin M; Kirkpatrick D; Nowak MJ; Strand R Cancer Genet Cytogenet; 1987 Sep; 28(1):155-62. PubMed ID: 2955885 [TBL] [Abstract][Full Text] [Related]
30. Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease. Mann DM; Yates PO; Marcyniuk B; Ravindra CR J Neurol Sci; 1987 Aug; 80(1):79-89. PubMed ID: 2956368 [TBL] [Abstract][Full Text] [Related]
31. White cells 2: impact of understanding the molecular basis of haematological malignant disorders on clinical practice. Stewart AK; Schuh AC Lancet; 2000 Apr; 355(9213):1447-53. PubMed ID: 10791539 [TBL] [Abstract][Full Text] [Related]
32. Calcification of the basal ganglia in Down's syndrome and Alzheimer's disease. Mann DM Acta Neuropathol; 1988; 76(6):595-8. PubMed ID: 2974228 [TBL] [Abstract][Full Text] [Related]
33. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease. Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071 [TBL] [Abstract][Full Text] [Related]